Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02138279 · ClinicalTrials.gov registry record
Comparative Study of Non-contact Tonometers for Intraocular Pressure and Corneal Cell Thickness Measurements
A clinical trial, sponsored by Topcon Medical Systems.
- Completed
- Registry status
- 65
- Enrollment target
NCT02138279: Completed study, sponsored by Topcon Medical Systems.
NCT02138279 is a clinical trial that has completed, run by Topcon Medical Systems. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02138279 has completed, sponsored by Topcon Medical Systems.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
The primary objective of this clinical study is to collect clinical data to support FDA 510(k) submissions for the Topcon CT-800, CT-1, CT-1P and TRK-2P non-contact tonometers. The secondary objective is to evaluate any adverse events found during the clinical study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2014-04 |
| Est. Completion | 2014-12 |
What the finished NCT02138279 record still lists
NCT02138279 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02138279 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02138279 about?
NCT02138279 is a clinical study titled "Comparative Study of Non-contact Tonometers for Intraocular Pressure and Corneal Cell Thickness Measurements". The primary objective of this clinical study is to collect clinical data to support FDA 510(k) submissions for the Topcon CT-800, CT-1, CT-1P and TRK-2P non-contact tonometers. The secondary objective is to evaluate any adverse events found during the clinical study.
What is the current status of trial NCT02138279?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2014-04. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT02138279?
This trial is sponsored by Topcon Medical Systems, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia